Cargando…

Controlling SIRT1 expression by microRNAs in health and metabolic disease

SIRT1 is a NAD(+-)dependent deacetylase implicated in longevity and diverse physiological processes. SIRT1, as a key mediator of beneficial effects of caloric restriction, regulates lipid and glucose metabolism by deacetylating metabolic regulators, as well as histones, in response to nutritional de...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jiyoung, Kemper, Jongsook Kim
Formato: Texto
Lenguaje:English
Publicado: Impact Journals LLC 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954045/
https://www.ncbi.nlm.nih.gov/pubmed/20689156
_version_ 1782187886736572416
author Lee, Jiyoung
Kemper, Jongsook Kim
author_facet Lee, Jiyoung
Kemper, Jongsook Kim
author_sort Lee, Jiyoung
collection PubMed
description SIRT1 is a NAD(+-)dependent deacetylase implicated in longevity and diverse physiological processes. SIRT1, as a key mediator of beneficial effects of caloric restriction, regulates lipid and glucose metabolism by deacetylating metabolic regulators, as well as histones, in response to nutritional deprivation. Here we discuss how SIRT1 levels are regulated by microRNAs (miRs) which are emerging as important metabolic regulators; the recently identified nuclear receptor FXR/SHP cascade pathway that controls the expression of miR-34a and its target SIRT1; and a FXR/SIRT1 positive feedback regulatory loop, which is deregulated in metabolic disease states. The FXR/miR-34a pathway and other miRs controlling SIRT1 may be useful therapeutic targets for age-related diseases, including metabolic disorders.
format Text
id pubmed-2954045
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-29540452010-10-14 Controlling SIRT1 expression by microRNAs in health and metabolic disease Lee, Jiyoung Kemper, Jongsook Kim Aging (Albany NY) Research Perspective SIRT1 is a NAD(+-)dependent deacetylase implicated in longevity and diverse physiological processes. SIRT1, as a key mediator of beneficial effects of caloric restriction, regulates lipid and glucose metabolism by deacetylating metabolic regulators, as well as histones, in response to nutritional deprivation. Here we discuss how SIRT1 levels are regulated by microRNAs (miRs) which are emerging as important metabolic regulators; the recently identified nuclear receptor FXR/SHP cascade pathway that controls the expression of miR-34a and its target SIRT1; and a FXR/SIRT1 positive feedback regulatory loop, which is deregulated in metabolic disease states. The FXR/miR-34a pathway and other miRs controlling SIRT1 may be useful therapeutic targets for age-related diseases, including metabolic disorders. Impact Journals LLC 2010-08-05 /pmc/articles/PMC2954045/ /pubmed/20689156 Text en Copyright: ©2010 Lee et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Perspective
Lee, Jiyoung
Kemper, Jongsook Kim
Controlling SIRT1 expression by microRNAs in health and metabolic disease
title Controlling SIRT1 expression by microRNAs in health and metabolic disease
title_full Controlling SIRT1 expression by microRNAs in health and metabolic disease
title_fullStr Controlling SIRT1 expression by microRNAs in health and metabolic disease
title_full_unstemmed Controlling SIRT1 expression by microRNAs in health and metabolic disease
title_short Controlling SIRT1 expression by microRNAs in health and metabolic disease
title_sort controlling sirt1 expression by micrornas in health and metabolic disease
topic Research Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954045/
https://www.ncbi.nlm.nih.gov/pubmed/20689156
work_keys_str_mv AT leejiyoung controllingsirt1expressionbymicrornasinhealthandmetabolicdisease
AT kemperjongsookkim controllingsirt1expressionbymicrornasinhealthandmetabolicdisease